Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets
Download the PDF here.
This post appeared first on investingnews.com
Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets
Download the PDF here.
This week, Microsoft (NASDAQ:MSFT) and OpenAI’s once tight alliance showed ...
Gold was on the decline this week, closing just below ...
Investment Insight Coelacanth Energy presents strong growth potential in the ...